Displaying drugs 451 - 475 of 2780 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Taurocholic acid | 515.703 C26H45NO7S |  | The product of conjugation of cholic acid with taurine. Its sodium salt is the chief ingredient of the bile of carnivorous animals. It acts as a detergent to solubilize fats... | Bile Acids and Salts / Cholagogues and Choleretics / Cholic Acids / Detergents / Gastrointestinal Agents / Steroids |
| Telmisartan | 514.6169 C33H30N4O2 |  | An ARB used to treat hypertension, diabetic nephropathy, and congestive heart failure. | Angiotensin II receptor blockers (ARBs) and calcium channel blockers / Angiotensin II receptor blockers (ARBs) and diuretics |
| Cefpirome | 514.577 C22H22N6O5S2 |  | An antibiotic indicated in the treatment of a wide variety of infections in the body. | Anti-Bacterial Agents / beta Lactam Antibiotics / Fourth-Generation Cephalosporins |
| Maraviroc | 513.6655 C29H41F2N5O |  | A CCR5 co-receptor antagonist used with other antiretroviral medications to treat CCR5-tropic HIV-1 infection. | CCR5 Co-receptor Antagonist / CCR5 Receptor Antagonists / Cyclohexanes / HIV Fusion Inhibitors / Triazoles |
| Strontium ranelate | 513.49 C12H6N2O8SSr2 |  | A medication used for the management of severe osteoporosis in high-risk postmenopausal women and adult men. | Bone Density Conservation Agents / Strontium |
| Thonzonium | 511.818 C32H55N4O |  | A cationic surfactant used to disperse exudate and cellular debris, as well as enhance the penetration of antimicrobials. | Amines / Ammonium Compounds / Nitrogen Compounds / Onium Compounds / Surface-Active Agents |
| Cefmenoxime | 511.558 C16H17N9O5S3 |  | Used to treat female gynecologic and obstetric infections caused by susceptible aerobic (including the gonococcus) and anaerobic bacteria. | Anti-Bacterial Agents / Third-Generation Cephalosporins |
| Pinaverium | 511.52 C26H41BrNO4 |  | A spasmolytic agent used for the symptomatic treatment of irritable bowel syndrome (IBS) and functional disorders of the biliary tract. | Calcium Channel Blockers / Parasympatholytics |
| Ripretinib | 510.367 C24H21BrFN5O2 |  | A kinase inhibitor used to treat advanced gastrointestinal stromal tumor (GIST). | Kinase Inhibitor |
| Argatroban | 508.64 C23H36N6O5S |  | A synthetic direct thrombin inhibitor used for the prevention and treatment of thrombosis related to heparin use. | Anticoagulants / Antithrombins |
| Procinonide | 508.559 C27H34F2O7 |  | Not Annotated | Not Annotated |
| Difluprednate | 508.5515 C27H34F2O7 |  | A topical corticosteroid used for the symptomatic treatment of inflammation and pain associated with ocular surgery. | Corticosteroids, Potent (Group III) |
| Linzagolix | 508.42 C22H15F3N2O7S |  | A selective gonadotropin-releasing hormone (GnRH) receptor antagonist used for the symptomatic treatment of uterine fibroids. | Anti-Gonadotropin-Releasing Hormones |
| Lefamulin | 507.73 C28H45NO5S |  | A pleuromutilin antibacterial used to treat community-acquired bacterial pneumonia (CABP). | Anti-Bacterial Agents |
| Latanoprostene bunod | 507.624 C27H41NO8 |  | A prostaglandin analog used to reduce ocular hypertension or treat open-angle glaucoma. | Prostaglandins, Synthetic |
| Ixabepilone | 506.7 C27H42N2O5S |  | A microtubule inhibitor administered in combination with capecitabine or alone in the treatment of metastatic or locally advanced breast cancer that has shown inadequate response to taxanes and anthracyclines. | Microtubule Inhibitors / Tubulin Modulators |
| Abemaciclib | 506.606 C27H32F2N8 |  | A medication used to treat HR+ HER2- advanced or metastatic breast cancer. | Cyclin-dependent kinase (CDK) inhibitors / Protein Kinase Inhibitors |
| Cefditoren | 506.578 C19H18N6O5S3 |  | A broad-spectrum third-generation cephalosporin antibiotic typically used to treat bacterial infections of the skin and respiratory tract. | Anti-Bacterial Agents / Third-Generation Cephalosporins |
| Tovorafenib | 506.29 C17H12Cl2F3N7O2S |  | A type II RAF inhibitor used to treat pediatric low-grade glioma with BRAF gene mutations. | B-Raf serine-threonine kinase (BRAF) inhibitors / BCRP/ABCG2 Inhibitors / Cytochrome P-450 CYP1A2 Inducers / Cytochrome P-450 CYP1A2 Inducers (strength unknown) / Cytochrome P-450 CYP2B6 Inducers / Cytochrome P-450 CYP2B6 Inducers (strength unknown) / Cytochrome P-450 CYP2C19 Inducers / Cytochrome P-450 CYP2C19 Inducers (strength unknown) / Cytochrome P-450 CYP2C19 Inhibitors / Cytochrome P-450 CYP2C19 inhibitors (strength unknown) / Cytochrome P-450 CYP2C19 Substrates / Cytochrome P-450 CYP2C8 Inducers / Cytochrome P-450 CYP2C8 Inducers (strength unknown) / Cytochrome P-450 CYP2C8 Inhibitors / Cytochrome P-450 CYP2C8 Inhibitors (strength unknown) / Cytochrome P-450 CYP2C8 Substrates / Cytochrome P-450 CYP2C9 Inducers / Cytochrome P-450 CYP2C9 Inducers (strength unknown) / Cytochrome P-450 CYP2C9 Inhibitors / Cytochrome P-450 CYP2C9 Inhibitors (strength unknown) / Cytochrome P-450 CYP2C9 Substrates / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inducers / Cytochrome P-450 CYP3A4 Inducers (strength unknown) / Cytochrome P-450 CYP3A4 Inhibitors / Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Heterocyclic Compounds, Fused-Ring / Sulfur Compounds |
| Amprenavir | 505.627 C25H35N3O6S |  | A protease inhibitor used to treat HIV infection. | Anti-HIV Agents / Antibiotics, Antitubercular / HIV Protease Inhibitors / Protease Inhibitors |
| Chlorhexidine | 505.447 C22H30Cl2N10 |  | An antiseptic used to sterilize for surgeries and in healthcare practice, to reduce pocket depth in periodontitis, and to treat gingivitis. | Anti-Infective Agents, Local / Antiinfectives and Antiseptics for Local Oral Treatment / Biguanides and Amidines / Medicated Dressings With Antiinfectives |
| Dipyridamole | 504.6256 C24H40N8O4 |  | A phosphodiesterase inhibitor used to prevent postoperative thromboembolic events. | Platelet Aggregation Inhibitors Excl. Heparin |
| Plerixafor | 502.782 C28H54N8 |  | A CXCR4 antagonist used in combination with granulocyte-colony stimulating factor to mobilize hematopoietic stem cells to the peripheral blood for collection and autologous transplantation in patients with non-Hodgkin’s lymphoma and multiple myeloma. | Anti-HIV Agents / Hematopoietic Stem Cell Mobilizer |
| Hexafluronium | 502.745 C36H42N2 |  | Used as an adjunct with succinylcholine (or suxamethonium chloride) to prolong muscle relaxation and to prevent succinylcholine-induced muscle fasciculations. | Nicotinic Antagonists |
| Amcinonide | 502.5717 C28H35FO7 |  | A topical corticosteroid used in the treatment of inflammation and pruritus due to a variety of dermatoses. | Corticosteroids, Potent (Group III) |
Displaying drugs 451 - 475 of 2780 in total